Steven Feldman to Injections, Subcutaneous
This is a "connection" page, showing publications Steven Feldman has written about Injections, Subcutaneous.
Connection Strength
0.658
-
Hall SL, Haidari W, Feldman SR. Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab J Drugs Dermatol. 2019 Aug 01; 18(8):822-823.
Score: 0.170
-
Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
Score: 0.161
-
Feldman SR. Psoriasis: the new and the old. J Drugs Dermatol. 2014 Aug; 13(8):894.
Score: 0.120
-
West C, Narahari S, O'Neill J, Davis S, Huynh M, Clark A, Boles A, Feldman SR. Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J. 2013 May 15; 19(5):18182.
Score: 0.111
-
Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol. 2008 Jan; 58(1):125-35.
Score: 0.076
-
Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes. 2008 Oct 02; 6:75.
Score: 0.020